Results 211 to 220 of about 76,869 (253)

Innate Immune Cell Infiltration Induced by Polatuzumab Vedotin Contributes to the Antitumor Effect in Mouse Models. [PDF]

EJHaem
Tomita M, Kawasaki N, Yorozu K, Shu S, Kato C, Kurasawa M, Masutani B, Sax N, Yamashita-Kashima Y, Yoshiura S.   +9 more
europepmc   +1 more source

A CCL5⁺CD20⁺CD8⁺ T cell subset drives pathogenic transformation of synoviocytes in rheumatoid arthritis via JAK-STAT signaling. [PDF]

Cell Biosci
Jia H, Xue J, Jiang S, Li W, Wei X, Wang Y, Zhuang J, Zhu X, Li H, Liu X, Chu M, Zhang Z, Zhang J.   +12 more
europepmc   +1 more source

Unraveling the role of IL-17A in the intestinal immune response against the protozoan parasite Giardia muris by an RNA sequencing approach [PDF]

, 2015
De Bosscher, Karolien, Dreesen, Leentje, Geldhof, Peter, Li, RW, Paerewijck, Oonagh, Ratman, Dariusz, Van Meulder, Frederik   +6 more
core  

Exploration of the mechanisms of HLWDD on skeletal muscle lesions under the influence of diabetes based on bioinformatics analysis and experimental validation. [PDF]

Front Nutr
Chen P, Yang H, Shi Z, Du L, Yin Y, Jiang B, Ma B.   +6 more
europepmc   +1 more source

<i>In ovo</i> carvacrol enriched inflammatory and T-cell transcriptional responses to <i>Escherichia coli</i> LPS in broiler chickens. [PDF]

Front Immunol
Meijer MMY, van den Brand H, Niknafs S, Roura E.   +3 more
europepmc   +1 more source

Fibroblast growth factor 21 (FGF21) promoter methylation drives the progression of chronic hepatitis B by mediating oxidative stress and inflammatory immunity. [PDF]

Microbiol Spectr
Li X, Zhang F, Zhu H, Tian Z, Xu M, Fan Y, Gao S, Wang K.   +7 more
europepmc   +1 more source

CD74⁺CCL5⁺ effector CD8⁺ T cells drive mucosal inflammation and predict biologics response in inflammatory bowel disease. [PDF]

J Transl Med
Wu S, Liu S, Zhang C, Yu B, Tan J, Liu X.   +5 more
europepmc   +1 more source

A high-resolution analysis of arrestin2 interactions responsible for CCR5 endocytosis. [PDF]

Elife
Petrovic I, Desai S, Isaikina P, Abiko LA, Spang A, Grzesiek S.   +5 more
europepmc   +1 more source

Targeting SHP2 to reverse immune evasion and resistance to anti-PD-1 therapy in non-small cell lung cancer. [PDF]

Cell Commun Signal
Chen S, Wang D, Xiong D, Zhang L, Li K, Wang J, Ma X, Hu X, Zeng L, Xu J, Wu Y.   +10 more
europepmc   +1 more source